| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,463 | -3.58% | |
| 6 months | ₹30,000 | ₹28,869 | -3.77% | |
| 1 year | ₹60,000 | ₹57,838 | -3.60% | |
| 3 years | ₹1,80,000 | ₹1,74,724 | -2.93% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Bosch Ltd | Consumer Discretionary | Equity | 6.55% |
| Pidilite Industries Ltd | Materials | Equity | 5.33% |
| Akzo Nobel India Ltd | Materials | Equity | 5.22% |
| Hero Motocorp Ltd | Consumer Discretionary | Equity | 5.14% |
| Marico Ltd | Consumer Staples | Equity | 5.08% |
| The Great Eastern Shipping Company Ltd | Energy & Utilities | Equity | 4.95% |
| Page Industries Ltd | Consumer Discretionary | Equity | 4.95% |
| AU Small Finance Bank Ltd | Financial | Equity | 4.85% |
| Mphasis Ltd | Technology | Equity | 4.74% |
| ABB India Ltd | Industrials | Equity | 4.69% |
| Britannia Industries Ltd | Consumer Staples | Equity | 4.22% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 4.15% |
| Bayer CropScience Ltd | Materials | Equity | 3.81% |
| Crisil Ltd | Industrials | Equity | 3.53% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 3.45% |
| Can Fin Homes Ltd | Financial | Equity | 3.31% |
| Abbott India Ltd | Healthcare | Equity | 3.30% |
| Muthoot Finance Ltd | Financial | Equity | 3.12% |
| Alkem Laboratories Ltd | Healthcare | Equity | 3.11% |
| Divi's Laboratories Ltd | Healthcare | Equity | 3.01% |
| HDFC Asset Management Company Ltd | Financial | Equity | 2.89% |
| Pfizer Ltd | Healthcare | Equity | 2.74% |
| Aptus Value Housing Finance India Ltd | Financial | Equity | 2.55% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 2.52% |
| UTI Asset Management Company Ltd | Financial | Equity | 2.38% |
| Others CBLO | Unspecified | CBLO | 0.54% |
| Net Payables | Unspecified | Net Payables | -0.14% |
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | -3.3% | -7.6% | +8.1% | +10.1% |
| Category average (Equity ELSS) | -4.2% | -8.0% | +10.1% | +16.7% |
| Rank (Equity ELSS) | -- | 23 | 31 | -- |